Company: SYRA
Filing Date: 2025-02-05
Form Type: S-3/A
Source: 0001493152-25-005032
Chunk: 20

Company: Syra Health Corp
Filing Date: 2025-02-05
Form: S-3/A
Chunk 20
---
 acquired, created or developed by, or which otherwise comes into the possession of any non-employee director or any holder of our preferred stock or any partner, member, director, stockholder, employee or agent of any such holder, other than someone who is an employee of our Company or our subsidiaries (“Covered Persons”), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise comes into the possession of a Covered Person in their capacity as our director.

Anti-Takeover Effects of Delaware law and Our Certificate of Incorporation and Bylaws

The provisions of Delaware law, our Certificate of Incorporation and our Bylaws described below may have the effect of delaying, deferring or discouraging another party from acquiring control of us.

| -12- |

Section 203 of the Delaware General Corporation Law

We are subject to Section 203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:

| ● | before                                                                                                                                   
 such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in        
 the stockholder becoming an interested stockholder;                                                                                      |
| ● | upon                                                                                                                                     
 completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned      
 at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining 
 the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by        
 persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to        
 determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or                      |
| ● | on                                                                                                                                       
 or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting        
 of the stockholder, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that         
 is not owned by the interested stockholder.                                                                                              |

In general, Section 203 defines business combination to include the following:

| ● | any                                                                                                                                 
 merger or consolidation involving the corporation and the interested stockholder;                                                   |
| ● | any                                                                                                                                 
 sale, transfer